Patents Assigned to ZANOPRIMA LIFESCIENCES LIMITED
  • Electronic cigarette compositions, devices, and related methods
    Patent number: 11690396
    Abstract: Disclosed herein is an inhalable composition, suitable for use in an electronic cigarette device, comprising at least 1 g/L of nicotine and at least 2 g/L of carbon dioxide dissolved or dispersed in a solvent comprising glycerol and water, wherein the molar ratio of carbon dioxide to nicotine is at least 0.1:1; wherein glycerol is present in an amount of at least 40% by weight, based on the total weight of the inhalable composition; wherein water is present in an amount of 1-20% by weight, based on the total weight of the inhalable composition; and wherein propylene glycol, when present, is present in an amount of no more than 10% by weight, based on the total weight of the inhalable composition.
    Type: Grant
    Filed: March 25, 2021
    Date of Patent: July 4, 2023
    Assignee: Zanoprima Lifesciences Limited
    Inventors: Ashok S. Narasimhan, Raymond McCague, Nicholas Hyde, William Jackson
  • Electronic cigarette compositions, devices, and related methods
    Patent number: 11684080
    Abstract: Disclosed herein is an inhalable composition, suitable for use in an electronic cigarette device, comprising at least 1 g/L of nicotine and carbon dioxide dissolved or dispersed in a solvent.
    Type: Grant
    Filed: October 23, 2019
    Date of Patent: June 27, 2023
    Assignee: Zanoprima Lifesciences Limited
    Inventors: Ashok S. Narasimhan, Raymond McCague, Nicholas Hyde, William Jackson
  • Process of making (S)-nicotine
    Patent number: 10913962
    Abstract: A process for synthetically producing (S)-nicotine ([(S)-3-(1-methylpyrrolidin-2-yl) pyridine]) is provided.
    Type: Grant
    Filed: March 12, 2019
    Date of Patent: February 9, 2021
    Assignee: ZANOPRIMA LIFESCIENCES LIMITED
    Inventors: Raymond McCague, Ashok Srinivasan Narasimhan
  • PROCESS
    Publication number: 20200157589
    Abstract: A process for synthetically producing (S)-nicotine ([(S)-3-(1-methylpyrrolidin-2-yl) pyridine]) is provided.
    Type: Application
    Filed: March 12, 2019
    Publication date: May 21, 2020
    Applicant: ZANOPRIMA LIFESCIENCES LIMITED
    Inventors: Raymond MCCAGUE, Ashok Srinivasan NARASIMHAN